Page last updated: 2024-08-26

9-hydroxyellipticine and s 16020-2

9-hydroxyellipticine has been researched along with s 16020-2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaminade, F; Delaporte, C; Jacquemin-Sablon, A; Le Mée, S; Markovits, J; Saucier, JM	1

Other Studies

1 other study(ies) available for 9-hydroxyellipticine and s 16020-2

Article	Year
Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain. Molecular pharmacology, 2000, Volume: 58, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Cloning, Molecular; Cricetinae; DNA; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ellipticines; Sequence Analysis, DNA; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2000

Article

Year

Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain.

Molecular pharmacology, 2000, Volume: 58, Issue:4

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Cloning, Molecular; Cricetinae; DNA; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ellipticines; Sequence Analysis, DNA; Topoisomerase II Inhibitors; Tumor Cells, Cultured

2000